The U.S. government plays a vitally important role in research and development for global health. Researchers are going in every single day and creating the cures for tomorrow. And so this is a bipartisan issue. The global health community have been incredibly concerned about proposed cuts that the administration has put forward. Had they gone through, we would have lost our leadership role, which would have been devastating. It sustained increases in funding or critical for biomedical researchers as they... Senator Blunt has chairman of the subcommittee on health and human services on the Senate side. He basically is the straw that stirs the drink in regard to whether things get funded or whether they don't get funded. And he is definitely a strong bipartisan leader. When you begin to hold back healthcare research, we also hold back our ability to move forward with life-saving cures. Termin once, reaction, mirrored the response of the global health community. He essentially rejected the cuts and provided a deep investment in the NIH and in CDC programs. He actively sought out other senators and really forged a bipartisan alliance to not only just protect a line but increase it to a level that really no one expected and give a tremendous boost to our Indian general. That was tremendous. When we pass this bill today, we will have increased health research spending in... The global health community views Chairman Blunt to be a key partner. He's a leader and a fierce advocate for global health programs. When you have someone like Senator Blunt who can work with the other side, then he's going to be a very strong advocate for a champion, if you will, and he indeed has been. I think we owe him a tremendous debt for his leadership. He is above and beyond a champion for global health R&D and definitely deserves the award.